Call Now

(800) 877-4520

Cottonwood Tucson | Addiction Treatment Center Cottonwood Tucson - A Unique, Authentic, Life Changing, Remarkable Experience

Arizona Addiction Rehab & Co-occurring Disorders Blog from Cottonwood de Tucson

Addiction recovery success has made Cottonwood de Tucson a leader in the field of alcoholism and drug dependency treatment.

Thursday, October 1, 2009

Bookmark and Share

Opioid Overdose Triples

The Centers for Disease Conntrol and Prevention (CDC) issued a very disturbing report yesterday in regard to deaths from opioid use. Opioids are the narcotic pain medications that include Vicodin, Lortabs, morphine, oxycodone, OxyContin, and methadone. They are used for pain relief and are all highly addicting. As I have said before the abuse of these drugs is growing faster than any other drugs of abuse. I have talked about the high risk of fatal overdoses in these medications which many people see as "safer" than cocaine and other drugs but I did not realize how bad the problem had gotten until this CDC report was relesaed.

The number of fatal overdoses from opioid medications has tripled sine 1999. Tripled. That's amazingly disturbing. Drug overdoses are now the second leading cause of injury death and in the 35-54 year age group the leading cause surpassing motor vehicle deaths! I did not know this.
It turns out that in half of those overdoses were accompanied by other drug use, particularly the benzodiazepines.

Thought for the day.

Used properly the opiods are wonderful to have for pain treatment. Used improperly they are poisons.

Labels: , ,

Tuesday, February 10, 2009

Bookmark and Share

FDA, Opioids, and Risk Evaluation and Mitigation Strategies

I noticed in the news today that the Food and Drug Administration (FDA) has plans to increase regulation of certain narcotic prescription pain medications, including OxyContin and morphine and Fentanyl patches. The FDA already regulates these medications as Schedule II narcotics but has not had the ability or authority to do more than make recommendations and monitor prescribing patterns. In 2007 a law was passed, the Risk Evaluation and Mitigation Strategies (REMS), that allows the FDA greater authority in it's ability to require both manufacturers of these drugs and prescribing physicians to follow certain guidelines.

The FDA is responding to a significant problem in that these medications, while successfully treating pain in cancer patients and chronic pain patients, are increasingly becoming drugs of misuse, abuse, diversion, and addiction. Prescription pain medications are now the number one abused substance after nicotine and alcohol. Pain medications have overtaken marijuana as the most commonly used drug in teenagers and their use is increasing. Here at Cottonwood abuse of these medications are the most commonly presenting addiction after alcoholism. Again, after alcoholism the addiction and misprescribing of these medications are the second most common reason for disciplinary actions of state boards of medicine. In addition to the addiction potential these medications are dangerous in overdoses and have been responsible for many deaths. These drugs can be lethal when mixed with certain sedatives and are believed to have been responsible for the tragic death of actor Heath Ledger last year.

Something clearly needs to be done about this problem. I support the FDA in taking a stronger stance on this issue. It is unclear what the new regulations will be but I am sure will include required additional training for physicians who wish to prescribe certain opioid pain medications. My support comes with some trepidation however. This will be the first regulatory action that will affect physician autonomy in prescribing. While necessary in this case I do have some concerns that REMS can be used in the future to limit physician autonomy in other areas of prescribing such as use of psychophamacologic medications in which proposed restrictions are motivated more by an ideological and political agenda rather than based upon science. We will have to wait and see.

Thought for the day

Change brings both opportunity and risk.

Labels: , , ,